It is important to note that physicians managing such patients have limited options, with several agents restricted (e.g. metformin or thiazolidinediones), and other agents that must be used carefully owing to safety concerns, including sulphonylurea agents and insulin that can lead to sodium retention, weight gain and hypoglycaemia. Here, INS is linked to Hypoglycemia.